New Non-Destructive Inspection, Blister Recovery and Packaging Technologies
Three new products aimed at meeting the changing demands of global pharma-companies are being introduced by the pharmaceutical packaging equipment specialist, Sepha Ltd. They will be formally launched at Interpack, Dusseldorf on 8-14th May 2014.
New Non-Destructive Inspection, Blister Recovery and Packaging Technologies launched by Sepha Ltd.
Three new products aimed at meeting the changing demands of global pharma-companies are being introduced by the pharmaceutical packaging equipment specialist, Sepha Ltd.
The first machine, BottleScan, is the world’s first tool-less, non-destructive leak detection instrument for testing multiple induction-sealed bottles simultaneously. It incorporates force decay technology to test induction-sealed bottles for holes and weak seals without destroying the contents. Ahead of itsEuropean debut, BottleScan has already attracted orders from Asian and North American customers.
Press Out Universal Mini is a low volume, rapid product change over deblistering unit that enables product to be recovered from all blister pack types, particularlychild resistant,peel-able and senior-friendly packs. The unit has been developed to reflect changes in the pharmaceutical manufacturing market, where manufacturers are focusing on shorter runs of more bespoke, high value drugs in child resistant or senior-friendly blister packs.
Finally, EZ MedPakextends Sepha's 'EZ' range of low volume, package development unitsinto the wider medical packaging market. It is aimed specifically at medical device and packaging development teams who want to take control of their own pack designs and develop bespoke packs for small devices and pre-filled syringes.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
